Myeloid-derived suppressor cells help protective immunity to Leishmania major infection despite suppressed T cell responses
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Th1/Th2 cytokines play a key role in immune responses to Leishmania major by controlling macrophage activation for NO production and parasite killing. MDSCs, including myeloid precursors and immature monocytes, produce NO and suppress T cell responses in tumor immunity. We hypothesized that NO-producing MDSCs could help immunity to L. major infection. Gr1hi(Ly6Chi) CD11bhi MDSCs elicited by L. major infection suppressed polyclonal and antigen-specific T cell proliferation. Moreover, L. major-induced MDSCs killed intracellular parasites in a NO-dependent manner and reduced parasite burden in vivo. By contrast, treatment with ATRA, which induces MDSCs to differentiate into macrophages, increased development of lesions, parasite load, and T cell proliferation in draining LNs. Altogether, these results indicate that NO-producing MDSCs help protective immunity to L. major infection, despite suppressed T cell proliferation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subpopulations of Mouse Blood Monocytes Differ in Maturation Stage and Inflammatory Response
Sunderkötter, C., Nikolic, T., Dillon, M. J., van Rooijen, N., Stehling, M., Drevets, D. A., & Leenen, P. J. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.4410 · Cited by 1,124
Benson, M. J., Pino-Lagos, K., Rosemblatt, M., & Noelle, R. J. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070719 · Cited by 847
Two physically, functionally, and developmentally distinct peritoneal macrophage subsets
Ghosn, E. E. B., Cassado, A. A., Govoni, G. R., Fukuhara, T., Yang, Y., Monack, D. M., Bortoluci, K. R., Almeida, S. R., Herzenberg, L. A., & Herzenberg, L. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915000107 · Cited by 689
The impact of vector-mediated neutrophil recruitment on cutaneous leishmaniasis
Peters, N. C., & Sacks, D. L. (2009) · Cellular Microbiology · doi:10.1111/j.1462-5822.2009.01348.x · Cited by 118
Cited by
Role of Vitamin A in the Immune System
Huang, Z., Liu, Y., Qi, G., Brand, D., & Zheng, S. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7090258 · Cited by 597
Regulation of iNOS on Immune Cells and Its Role in Diseases
Xue, Q., Yan, Y., Zhang, R., & Xiong, H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123805 · Cited by 421
Mechanisms of Immune Evasion in Leishmaniasis
Gupta, G., Oghumu, S., & Satoskar, A. R. (2013) · Advances in Applied Microbiology · doi:10.1016/b978-0-12-407679-2.00005-3 · Cited by 259
On the armament and appearances of human myeloid-derived suppressor cells
Poschke, I., & Kiessling, R. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.06.003 · Cited by 177
“recently demonstrated that NO-mediated killing of parasites by MDSC helps to control Leishmania major infections in mice despite concurrent T cell suppression [122].”
BackgroundRay, A., Chakraborty, K., & Ray, P. (2013) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2013.00052 · Cited by 108
“…IL-10 De Santo et al., 2008; Jeisy-Scott et al., 2011 Parasite CD11b+Gr1+ Mediator: NO Reviewed in Van Ginderachter et al., 2010 CD11bhiLy6ChiF4/80int (Leishmania major ) Kills parasites and inhibits T cell proliferation Mediator: NO Pereira et al., 2011 the efficacy of imiquimod (Lu et al., 2010).”
Background
Metadata
- Authors
- Pereira, W. F., Ribeiro-Gomes, F. L., Guillermo, L. V. C., Vellozo, N. S., Montalvão, F., DosReis, G. A., & Lopes, M. F.
- Venue
- Journal of Leukocyte Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-09-20
- Volume
- 90
- Issue
- 6
- Pages
- 1191-1197
- ISSN
- 0741-5400 (ISSN-L)
- 1938-3673
- OpenAlex
- W2156246029
- Cited by
- 58
- References
- 4
- FWCI
- 4.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.